(Total Views: 510)
Posted On: 02/19/2022 9:38:40 PM
Post# of 148939
Re: Goosebumps #118726
I think the deal was we were only slightly better mOS at 12.3 months or something. By now in months if the small patient sample has survived, we could be approaching mOS of 16-18 months.
I’m not sure what that would get us. Maybe BTD, SOC. But nonetheless, If that is the case. And NASH BTD is forthcoming And PDUFA And LH (big ifs), then buying us out isn’t going to get any cheaper.
Best get about it, if you’re a company that might want to own the miracle molecule. Time and money’s a-wasting.
It’s a record breaking drug. Why not a record breaking buyout.
(ps- I think the thing that got me off on this tangent is the 60 day FDA window for a BTD. Seems we’re 5/8ths through that now. Square pegs.)
I’m not sure what that would get us. Maybe BTD, SOC. But nonetheless, If that is the case. And NASH BTD is forthcoming And PDUFA And LH (big ifs), then buying us out isn’t going to get any cheaper.
Best get about it, if you’re a company that might want to own the miracle molecule. Time and money’s a-wasting.
It’s a record breaking drug. Why not a record breaking buyout.
(ps- I think the thing that got me off on this tangent is the 60 day FDA window for a BTD. Seems we’re 5/8ths through that now. Square pegs.)
(4)
(0)Scroll down for more posts ▼
